Posted by Michael Wonder on 17 Jan 2017
Introducing IMEDS, a public-private resource for evidence generation
17 January 2017 - The FDA has been working to establish a national resource for FDA-approved medical products that can be used by public and private-sector entities, including regulated industry, to conduct large scale evaluations of safety issues in an environment that is secure and protects patient privacy.
These evaluations include epidemiologic studies of medical products in collaboration with multiple healthcare data partners and the analytic center utilised by FDA through the agency’s Sentinel System. This new resource is called the Innovation in Medical Evidence Development and Surveillance System, or IMEDS.
